Speaker illustration

Mr Rodolfo Antonio Montiel Quintero

Brussels Universitary Hospital, Bruxelles (Belgium)

Member of:

European Society of Cardiology
European Heart Rythm Association

Initial experience of pharmacological treatment with sacubitril-valsartan: baseline clinical characteristics and follow-up at one year of clinical use

Event: Heart Failure 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb